Repligen
RGEN
#2741
Rank
S$8.04 B
Marketcap
S$142.61
Share price
-5.18%
Change (1 day)
-24.11%
Change (1 year)
Categories

Repligen (RGEN) Fails to deliver data

Key failure to deliver metrics for Repligen :

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Repligen (RGEN) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Repligen (RGEN) - since 2013

Volume in USD (price x number of shares), data since 2013

Repligen (RGEN) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2026S$8.1 M-62.96%
2025S$21.87 M-36.33%
2024S$34.35 M-68.17%
2023S$0.10 B60.05%
2022S$67.43 M90.89%
2021S$35.32 M-76.42%
2020S$0.14 B197.63%
2019S$50.34 M-29.09%
2018S$70.99 M835.37%
2017S$7.59 M22.08%
2016S$6.21 M-19.68%
2015S$7.74 M-7.23%
2014S$8.34 M721.71%
2013S$1.01 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Pfizer
PFE
S$23.8 MS$0.12 B๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
S$4.93 MS$58.59 M๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
S$33.66 MS$0.24 B๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$20.35 MS$70.85 M๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
S$0.45 MS$8.18 M๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
S$12.4 MS$65.68 M๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
S$3.75 MS$18.78 M๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
S$12.73 MS$30.64 M๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$5 MS$17.4 M๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
S$17.99 MS$0.13 B๐Ÿ‡บ๐Ÿ‡ธ USA